Prognostic factors and early risk-adapted therapy in patients with chronic lymphocytic leukemia in Binet stage A Not provided at time of registration

• Country Germany
• organs None
• Specialty None

Phase III trial of combined immunochemotherapy with Fludarabine, Cyclophosphamide and Rituximab (FC-R) versus chemotherapy with Fludarabine and Cyclophosphamide (FC) alone in patients with previously untreated chronic lymphocytic leukaemia Not provided at time of registration

• Country Germany
• organs None
• Specialty None

CLL7 : Essai de phase 3 randomisé comparant l’efficacité d’un traitement précoce associant du rituximab à de la fludarabine et de la cyclophosphamide à un traitement après progression, chez des patients ayant une leucémie lymphoïde chronique. [Informations issues du registre américain PDQ et traduites par l'INCa] [essai clos aux inclusions] Randomized phase III trial comparing early treatment with fludarabine/cyclophosphamide + rituximab versus deferred treatment in untreated binet stage a patients with CLL and high risk of progression.

• Country France
• organs Leucémies chroniques
• Specialty Chimiothérapie, Thérapies Ciblées